Bringing the fundamentals into focus…
Back to Legend Biotech Corporation
How Legend Biotech Corporation stacks up
LEGN · against 233 other Healthcare companies of similar size
Growth
93/ 100
Near the top of its peers.
Ranked #17 of 234 · scores higher than 93% of peers
Bars: peers in each 10-point band of the growth score32 peers with a growth score of 90–100, including LEGN · Click a bar to see the companies
Why growth scores 93?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 92% of peers. Revenue growth: 64.0% vs peer median 6.1%
- faster revenue growth over three years: stronger than 97% of peers. 3-year revenue growth: 106.4% vs peer median 5.8%
Metric by metric
Position: dot = LEGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LEGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 233 reported | 64.0% | 7.8% | 92% | 33% | |
| Earnings per share growthHigher is better · 151 reported | Not reported | 12.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 228 reported | 106.4% | 8.3% | 96% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around LEGN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 13 | 3.4B USD | 96 | 48 | |
| 15 | 3.0B USD | 95 | 54 | |
| 15 | 4.7B USD | 95 | 42 | |
| 17 | 22.1B CNY (≈$3.1B) | 93 | 49 | |
| 17 | 4.2B USD | 93 | 44 | |
| 19 | 2.2B USD | 92 | 82 | |
| 19 | 7.3B USD | 92 | 32 | |
| 19 | 2.7B USD | 92 | 50 | |
| 19 | 2.3B USD | 92 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score